Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents

por Spratt, Austin N., Gallazzi, Fabio, Quinn, Thomas P., Lorson, Christian L., Sönnerborg, Anders, Singh, Kamal
Publicado 2021

Omicron SARS-CoV-2 variant: Unique features and their impact on pre-existing antibodies

por Kannan, Saathvik R., Spratt, Austin N., Sharma, Kalicharan, Chand, Hitendra S., Byrareddy, Siddappa N., Singh, Kamal
Publicado 2022

Continued Complexity of Mutations in Omicron Sublineages

por Spratt, Austin N., Kannan, Saathvik R., Sharma, Kalicharan, Sachdev, Shrikesh, Kandasamy, Shree L., Sönnerborg, Anders, Lorson, Christian L., Singh, Kamal
Publicado 2022

Infectivity of SARS-CoV-2: there Is Something More than D614G?

por Kannan, Saathvik R., Spratt, Austin N., Quinn, Thomas P., Heng, Xiao, Lorson, Christian L., Sönnerborg, Anders, Byrareddy, Siddappa N., Singh, Kamal
Publicado 2020

Complex Mutation Pattern of Omicron BA.2: Evading Antibodies without Losing Receptor Interactions

por Kannan, Saathvik R., Spratt, Austin N., Sharma, Kalicharan, Goyal, Ramesh, Sönnerborg, Anders, Apparsundaram, Subbu, Lorson, Christian L., Byrareddy, Siddappa N., Singh, Kamal
Publicado 2022

Evolution, correlation, structural impact and dynamics of emerging SARS-CoV-2 variants

por Spratt, Austin N., Kannan, Saathvik R., Woods, Lucas T., Weisman, Gary A., Quinn, Thomas P., Lorson, Christian L., Sönnerborg, Anders, Byrareddy, Siddappa N., Singh, Kamal
Publicado 2021

Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses

por Kannan, Saathvik R., Spratt, Austin N., Cohen, Alisha R., Naqvi, S. Hasan, Chand, Hitendra S., Quinn, Thomas P., Lorson, Christian L., Byrareddy, Siddappa N., Singh, Kamal
Publicado 2021